The Instructions for Use direct patients to check that the expiration date has not passed and not to use the product if it has
The VA offers several alternative pathways to support your health journey
Rushing to higher doses frequently results in severe nausea, vomiting, and premature discontinuation
evolving evidence and careful monitoring can allow TRT in select patients after appropriate oncologic clearance
Most recently on 8 November 2023, the US Food and Drug Administration approved through an expedited process the use of tirzepatide (Zepbound) for chronic weight management in adults with obesity, reflecting the urgent need to address gaps in obesity treatment
And if you found this conversation helpful, please share it with your family, friends, and community